BioNTech says developed method to detect high-risk corona virus variants
The new computational method can analyse genetic sequencing data of new corona virus mutations found in infected people and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BioNTech
Moderna to produce millions of mRNA vaccines in Australia
The deal underscores efforts by governments around the world to build up local production and prepare for future pandemic threats…
Pfizer raises COVID vaccine sales forecast to $36 billion for 2021
The company had, in July, forecast sales of $33.5 billion from the vaccine it sells with BioNTech
Brazil’s Eurofarma to make Pfizer COVID-19 shots for Latin America
The company is expected to produce more than 100 million finished doses annually at full operational capacity
Turkish COVID-19 vaccine starts phase-III trials
Turkey also granted an emergency use authorisation for Russia’s Sputnik V. People over 25 are eligible for the vaccine
COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research
PHE said that while the Pfizer/BioNTech vaccine was 88 per cent effective against symptomatic COVID-19 from the B1.617.2 variant…
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side…
Pfizer/BioNTech’s vaccine to touch sales of $24.8 billion by 2021: GlobalData
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have peak sales of $24.8bn by 2021, which is only its second year on the…
Pfizer COVID-19 vaccine safe, efficacious for adolescents
Whether COVID-19 vaccines work and are safe to use on children is one of the big questions drugmakers are trying to answer
COVID-19 vaccines from Pfizer, Moderna very effective after first shot: US real-world study
The risk of infection fell 90 per cent by two weeks after the second shot, the study of nearly 4,000 US healthcare personnel and…